Open the mobile version, with barcode scanning
Class II Terminated

CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Col…

Why: CGMP Deviations

Company
Edge Pharma, LLC
Colchester, VT, United States
Reported
Feb 2, 2022
Recall started
Dec 6, 2021
Ended
Jun 7, 2023
Where sold
nationwide
Amount
1055 bottles
Full product description
CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1633-05
Lots / codes affected
10-2021-27@8 01-25-2022

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.